EPIGENETICS IN CANCER INITIATION ๐️
“๐๐ฐ๐ฎ-๐ช๐ผ๐ผ๐ธ๐ฌ๐ฒ๐ช๐ฝ๐ฎ๐ญ ๐ฎ๐น๐ฒ๐ฐ๐ฎ๐ท๐ฎ๐ฝ๐ฒ๐ฌ ๐ฌ๐ฑ๐ช๐ท๐ฐ๐ฎ๐ผ ๐ถ๐ช๐ ๐น๐ป๐ฒ๐ถ๐ฎ ๐ฌ๐ฎ๐ต๐ต๐ผ ๐ฏ๐ธ๐ป ๐ถ๐ช๐ต๐ฒ๐ฐ๐ท๐ช๐ท๐ฝ ๐ฝ๐ป๐ช๐ท๐ผ๐ฏ๐ธ๐ป๐ถ๐ช๐ฝ๐ฒ๐ธ๐ท ๐ต๐ธ๐ท๐ฐ ๐ซ๐ฎ๐ฏ๐ธ๐ป๐ฎ ๐ถ๐พ๐ฝ๐ช๐ฝ๐ฒ๐ธ๐ท๐ผ ๐ช๐ฌ๐ฌ๐พ๐ถ๐พ๐ต๐ช๐ฝ๐ฎ.” - Professor Anne Brunet
๐งฌ Epigenetics (heritable changes in gene expression without DNA sequence alteration) is increasingly recognized as a driver of early cancer initiation, not just a downstream effect. It shapes cellular identity, yet its dysregulation can quietly reprogram cells toward malignancy.
๐น Aberrant hypermethylation silences tumor suppressor genes, while global hypomethylation promotes genomic instability and oncogene activation. These early shifts often precede detectable mutations, suggesting epigenetic “priming.”
๐น Altered acetylation and methylation reshape chromatin accessibility, tipping the balance toward proliferation and away from apoptosis (key hallmarks of early tumorigenesis).
๐น Dysregulated miRNAs disrupt post-transcriptional control, weakening tumor suppression and amplifying oncogenic signaling networks.
➡️ Environmental exposures (e.g., tobacco, diet, pollutants) further accelerate these changes, linking lifestyle and aging to cancer risk through cumulative epigenetic drift.
⚠️ In an Oystershell, unlike genetic mutations, epigenetic alterations are potentially reversible; making them powerful targets for early detection, prevention, and precision therapy.
Abubakar Abubakar ✍๐ป
• Jones, P.A., & Baylin, S.B. (2007). The epigenomics of cancer. Cell.
• Feinberg, A.P., & Tycko, B. (2004). The history of cancer epigenetics. Nat Rev Cancer.
• Baylin, S.B., & Jones, P.A. (2016). Epigenetic determinants of cancer. Cold Spring Harb Perspect Biol.
• Esteller, M. (2008). Epigenetics in cancer. N Engl J Med.
Comments
Post a Comment